Retinoid-deficient cultures of airway epithelial cells undergo squamous differentiation. Treatment of such cultures with retinoic acid (RA) leads to restoration of the mucous phenotype. The purpose of our study was to characterize the cellular and molecular changes following RA treatment of retinoid-deficient human tracheobronchial epithelial cell cultures. Of particular interest was to determine when during the conversion of the squamous to the mucous phenotype the mucin genes MUC2 , MUC5AC , and MUC5B were expressed. We used cornifin ␣ and secreted mucin as markers to monitor the squamous and mucous phenotypes, respectively. Our studies showed that the RA responsiveness of the cultures progressively decreased with protracted retinoid deficiency, requiring higher RA concentrations to restore the mucous phenotype. Within 12 h after the start of RA treatment, cornifin ␣ expression decreased, signaling the beginning of a change in cellular phenotype. At 24 h after addition of RA to the cultures, a significant number of mucous cells appeared, and at 72 h mucin was secreted in measurable amounts. Induction of mucin gene expression occurred sequentially: MUC2 , MUC5AC , and MUC5B mRNAs were upregulated at 24, 48, and 72 h, respectively. When cultures maintained in 10 Ϫ 8 M RA were treated with 10 Ϫ 6 M RA, MUC2 but not MUC5AC and MUC5B mRNA levels were upregulated within 6 h. Our study indicates that MUC2 mRNA is an early marker of mucous differentiation, whereas MUC5AC and MUC5B mRNAs are expressed during more advanced stages of mucous differentiation. Our studies further suggest that each of the mucin genes is regulated by distinct mechanisms. Vitamin A (retinol) and related compounds, summarily called retinoids, are known to regulate cell proliferation, differentiation, and morphogenesis. Their effects are mediated through nuclear retinoid receptors, retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which can activate or repress transcription of a multitude of target genes (1). Numerous studies have shown that retinoids are important for normal lung development and maturation, and since the pioneering studies of Mori (2) and Wolbach and Howe (3), it is known that vitamin A is essential for the maintenance of the mucociliary epithelium in the conducting airways (4-7). Chronic vitamin A deficiency leads to replacement of the mucociliary epithelium by a stratified squamous epithelium, and reversal of this abnormal form of differentiation has been reported to occur within a few days after vitamin A was restored to the diet (8). In vitro studies with tracheal explants and primary epithelial cells have shown that in the absence of retinoids the cultures undergo squamous differentiation and that addition of vitamin A to the medium restores mucous differentiation (5, 9-11).
are important for normal lung development and maturation, and since the pioneering studies of Mori (2) and Wolbach and Howe (3), it is known that vitamin A is essential for the maintenance of the mucociliary epithelium in the conducting airways (4) (5) (6) (7) . Chronic vitamin A deficiency leads to replacement of the mucociliary epithelium by a stratified squamous epithelium, and reversal of this abnormal form of differentiation has been reported to occur within a few days after vitamin A was restored to the diet (8) . In vitro studies with tracheal explants and primary epithelial cells have shown that in the absence of retinoids the cultures undergo squamous differentiation and that addition of vitamin A to the medium restores mucous differentiation (5, (9) (10) (11) .
We have been interested in elucidating the role of retinoids in mucous cell differentiation and mucin gene expression (12) (13) (14) . Using cultured tracheobronchial epithelial cells from rats and humans, we previously showed that the development of the mucous phenotype as well as expression of MUC2 and MUC5AC depend on the presence of retinoids in the culture media. In the absence of retinoic acid (RA), MUC2 and MUC5AC mRNA levels were very low or undetectable (13, 14) and the cultures contained very few mucous cells (15) . The purpose of our study was to examine changes in expression of mucin genes and the squamous differentiation marker cornifin ␣ (16) during the restoration of the mucous phenotype following RA treatment of RA-deficient cultures.
We concentrated on the mucin genes MUC2 , MUC5AC , and MUC5B for the following reasons: MUC2 , even though it is only weakly expressed in normal bronchial epithelium and may not be a major secreted mucin (17) , has been shown to be markedly upregulated in cystic fibrosis patients (18) ; MUC5AC and MUC5B mucins, on the other hand, have been shown to be major components of human airway secretions (19) (20) (21) . Furthermore, several investigators have demonstrated that the expression of MUC2 and MUC5AC mucin genes is regulated by cytokines and bacterial products (18, (22) (23) (24) . Athough it is not clear at the moment whether other mucins are also significant components of human airway secretions and to what extent the mixture of mucins changes in disease, it appears that MUC5AC and MUC5B mucins are important constituents of tracheobronchial secretions and that MUC2 mRNA levels are regulated by factors causing hypersecretion.
Our studies showed that the vitamin A-deficient cultures became progressively less responsive to RA. Tenfold higher concentrations were required to reestablish the mucous phenotype in late compared with early vitamin A-deficient cultures. After RA treatment, cornifin ␣ mRNA was suppressed at 12 h; MUC2 , MUC5AC , and MUC5B mRNAs were induced at 24, 48, and 72 h, respectively; and mucous cells reappeared at 24 h, but mucin was not secreted until 72 h. Our study delineates a progressive chain of events during remodeling of the RA-deficient squamous epithelium triggered by RA treatment, starting with repression of the squamous differentiation program, followed by sequential expression of mucin genes and culminating in mucin secretion.
We also compared the kinetics of mucin gene induction in RA-deficient and RA-sufficient cultures following treatment with high doses of RA. We found that MUC2 , but not MUC5AC and MUC5B , was much more rapidly upregulated in RA-sufficient than in RA-deficient cultures, that is, within 6 h rather than 24 h. This suggests perhaps that in RA-sufficient cultures RA affects MUC2 transcription more directly than in RA-deficient cultures, in which induction of mucin genes occurs as part of complex changes in the differentiation program.
Materials and Methods

Air-Liquid Interface Cultures and RA
Normal human tracheobronchial epithelial (NHTBE) cells (strains 2002 and 17684; Clonetics Co., San Diego, CA) from passage 2 were seeded at a density of 1 ϫ 10 5 cells onto 24-mm permeable membranes in serum-free, hormone-and growth-factor-supplemented medium as described previously (15) except for the following changes. Instead of using Transwell-COL, we used Transwell-clear membranes (Costar Co., Cambridge, MA). Because we found that NHTBE cells grew and differentiated equally well on these membranes regardless of the presence or absence of collagen gel (14) , we seeded the cells directly onto the membranes. All trans -retinoic acid (Sigma, St. Louis, MO) was dissolved in dimethyl sulfoxide (DMSO) and stored at Ϫ 20 Њ C until needed. The final DMSO concentration in the medium was never greater than 0.1%. Control cultures were treated with DMSO only.
Histology and Cytology
For histologic analysis, cultures were fixed in 10% neutral buffered formalin, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (H&E). Cytospin slides and cell pellets were prepared from cell suspensions obtained following enzymatic dissociation of cultures and were fixed and stained as described previously using the 17Q2 antibody (15) .
Immunoassays
The dot-blotting assay for quantitation of secreted mucin and the immunocytochemical methods for quantitating mucous cells using antibodies 17Q2 and H6C5 have been described previously (15) . In short, apical secretions accumulating during a 24-h period were collected using 1.5 ml phosphate-buffered saline. Dilutions of apical secretions and mucin standards were applied to nitrocellulose membranes, reacted with the antimucin antibody, and followed by reaction with horseradish peroxidase-conjugated secondary antibody. The signal was detected by chemiluminescence (ECL kit; Amersham, Arlington Heights, IL), and a standard curve was generated by linear regression analysis from which the concentration of mucin of individual samples could be determined. Antibody 17Q2 (a generous gift from Dr. J. St. George, Genzyme, Framingham, MA) was prepared against rhesus monkey tracheal secretions and shown to react with human goblet cells (25, 26) . Antibody H6C5 (a generous gift from Dr. C. William Davis, University of North Carolina at Chapel Hill) was prepared against high molecular weight components of human cystic fibrosis sputum obtained according to procedures described by Thornton and colleagues (27) . Antibodies H6C5 and 17Q2 have previously been shown to give similar results in both dot-blotting analysis and quantitation of immunopositive cells (15) . Because of the limited supply of 17Q2 antibody, we used it for immunostaining of cytospins at a dilution of 1:250. This antibody gives a better staining of secretory granules. The H6C5 antibody was mostly used for dot blotting of secretions (dilution 1:250). Human mucin purified from cystic fibrosis sputum (0.85 mg dry weight of purified protein per milliliter) was used as mucin standard. The amount of secreted mucin was presented as micrograms of mucin per 10 6 cells. To determine the number of cells per culture, the cultures were enzymatically dissociated and the cells were visually counted by using a hemacytometer. The data are represented as the means Ϯ SD of triplicate cultures. Statistical comparisons were made using Student's t test. Immunolabeling of mucous cells were quantitated by scoring 1,500 cells from 10 random fields on each slide as described previously (15) .
Isolation of Total RNA and Northern Blot Analysis
Total RNA was isolated from pools of triplicate cultures using Tri-Reagent (Molecular Research Center, Cincinnati, OH). Five micrograms of RNA samples were separated in 1.4% agarose-formaldehyde gel electrophoresis and transferred overnight onto Nytran membrane (Schleicher & Schuell, Keene, NH) by capillary action (28) . The filters were dried, baked for 2 h at 80 Њ C, and prehybridized for 30 min at 68 Њ C in 15 ml of QuickHyb Hybridization solution (Stratagene, La Jolla, CA). Radiolabeling of 20 to 50 ng of cornifin ␣ cDNA (16) fragment was performed using redi -Prime random primer labeling kit (Amersham) and [ ␣ -32 P] deoxycitidine triphosphate (DuPont NEN, Wilmington, DE) according to manufacturer's recommendations. The filters were hybridized with the radiolabeled probes (specific activity of ‫ف‬ 10 9 cpm/ g DNA) and 1 mg of boiled salmon sperm DNA for 1 h at 68 Њ C. Membranes were washed three times with 2 ϫ saline sodium citrate (SSC)/0.1% sodium dodecyl sulfate (SDS) for 15 min at room temperature, once for 30 min at 60 Њ C in 0.1 ϫ SSC/ 0.1% SDS, and once for 5 min at room temperature in 0.1 ϫ SSC/0.1% SDS. Membranes were placed in contact with Hyperfilm-MP autoradiography film (Amersham) with an intensifying screen at room temperature for 30 to 60 min. Equivalent loading of the RNA samples was determined by ethidium bromide staining of 28S ribosomal RNA of the agarose-formaldehyde gel.
Quantitative Reverse Transcriptase-Polymerase Chain Reaction
Methods to detect MUC2 and MUC5AC mRNA levels using quantitative reverse transcriptase-polymerase chain reaction (RT-PCR) have been reported elsewhere in detail (13) . Oligonucleotide primers for RT-PCR were designed according to the published sequences for human MUC2 (29; Genbank accession no. L21998, 5 Ј primer: TGC CTG GCC CTG TCT TTG; 3 Ј primer: CAG CTC CAG CAT GAG TGC); and human MUC5AC (30; Genbank accession no. U06711, 5 Ј primer: TCC GGC CTC ATC TTC TCC; 3 Ј primer: ACT TGG GCA CTG GTG CTG); and human MUC5B (31; Genbank accession no. Z72496, 5 Ј primer: ACT CCA GAG ACT GTC CAC AC; 3 Ј primer: TAC CAC TGG TCT GTG TGC TA). The MUC2 oligonucleotides generated the expected 440-bp fragment, MUC5AC oligonucleotides generated a 680-bp fragment, and MUC5B amplimers produced a 388-bp fragment. All of the amplimers for mucin mRNA were designed to bind nontandem repeat regions of the respective genes. Oligonucleotide amplimers for ␤ 2 microglobulin ( ␤ 2M, which was used as a control gene for RT-PCR) were purchased from Clontech (Palo Alto, CA) and generated a 335-bp PCR fragment.
PCRs for MUC2 and MUC5AC were performed as described previously (13) . For PCR of MUC5B , 27 cycles of denaturation (95 Њ C/1 min), annealing (55 Њ C/1 min), and extension (72 Њ C/1 min) were used in the presence of 1.5 mM MgCl 2 followed by 20 min extension at 72 Њ C. PCRs were done in the presence of an internal standard-the socalled MIMIC (32, 33)-which is double-stranded DNA with ends that are complementary to the specific MUC2 , MUC5AC or MUC5B primers but contain different lengths of stuffer sequences with no homology to the MUC2 , MUC5AC , and MUC5B target sequences. The gene-specific primers hybridize to both the target genes and the MIMICs in a competitive manner, and the PCR amplification products are identified by the length of DNA between two primers. A similar amplification efficiency and mutual competition of target cDNA and MIMIC were demonstrated by the titration of PCR cycle number and amount of MIMIC cDNA, respectively.
To calculate changes in the levels of MUC2 and MUC5AC mRNAs, RT-PCRs were performed in the presence of 10 Ϫ 3 amol MIMIC per PCR, except for the experiment summarized in Figure 5 in which 10 Ϫ 2 amol MIMIC was used for MUC5AC because the MUC5AC signal was very strong. For MUC5B , 10 Ϫ 1 amol MIMIC per PCR was used. PCR products were separated by electrophoresis on a 2% Seakem agarose gel (FMC, Rockland, ME) containing ethidium bromide (50 ng/ml), and the resulting bands were captured by an IS-1000 digital imaging system (Alpha Innotech Co., San Leandro, CA) or were photographed with Polaroid type 55 film. The intensity of the bands was analyzed using IA-200 image analysis software provided by the manufacturer (Alpha Innotech). The ratio of the signal intensity of the target DNA to the MIMIC was used to estimate the relative abundance of the target mRNA among the various samples. When mucin mRNA was undetectable, the lower limit of detection (2.5 ϫ 10 Ϫ 5 amol/ g total RNA) (13) was used to estimate the relative changes in mRNA levels. Specific amplification of MUC2 , MUC5AC , and MUC5B mRNAs was confirmed by sequencing (dsDNA Cycle Sequencing System; GIBCO BRL, Gaithersburg, MD) the PCR fragments.
Results
Changes in RA Responsiveness of NHTBE Cells with Time in Culture
We previously showed that in the absence of retinoid NHTBE cell cultures differentiate into a stratified squamous epithelium instead of a columnar mucous epithelium (15) . We found that 10 Ϫ 8 to 10 Ϫ7 M RA is required to maintain mucous differentiation. To study the reversibility of squamous differentiation by RA, cells were grown for various lengths of time in RA-free medium, and at either Day 7, 8, 9, 10, or 11 the cultures were treated for 4 d with 10 Ϫ7 M RA. Control cultures were sham treated. To monitor changes in squamous and mucous differentiation, we measured cornifin ␣ mRNA as a marker of squamous differentiation (16) and apically secreted mucin as a marker of mucous differentiation (15), respectively. As seen in Figure 1A , RA-deficient cultures secreted little or no mucin. Treatment of Day 7, RA-deprived cultures with RA over a 4-d period resulted in production of large amounts of mucin. When RA treatment was started at later times (Days 8 to 11), the ability of RA to induce mucin steadily decreased. In all RA-treated cultures, cornifin ␣ mRNA was strongly suppressed ( Figure 1B ) regardless of when RA treatment was initiated. These data suggest that the cultures remained RA responsive, even though restoration of the mucous phenotype appeared to be less effective when the onset of treatment was delayed.
RA Dose-Dependent Effects on Mucin and Cornifin ␣ Gene Expression
To define more precisely the changes of RA responsiveness of early and late RA-depleted cultures, NHTBE cells grown for either 7 or 10 d in RA-free medium were treated with different concentrations of RA. Four days after the start of treatment, the mRNA levels of MUC2 and MUC5AC, and of cornifin ␣ were determined using quantitative RT-PCR (13) and Northern blotting, respectively.
As is shown in Figure 2 Ϫ5 M RA, expression of both mucin genes was less than that observed with 10 Ϫ6 M RA, suggesting that 10 Ϫ5 M RA may be toxic. We also monitored the effect of RA treatment on cornifin ␣ gene expression. Cornifin ␣ mRNA levels were markedly reduced by 10 Ϫ8 M RA in cultures treated on Day 7, whereas in cultures treated on Day 10, 10 Ϫ7 M RA was required to cause a significant reduction. These studies showed that the responsiveness of NHTBE cultures to RA treatment decreased with time. The longer the cells were maintained in RA-free medium, the more RA was required to induce the two mucin genes and to inhibit cornifin ␣ mRNA expression. The studies also showed that MUC5AC, in comparison with MUC2, required higher RA concentrations for induction of gene expression. 
Histologic and Immunocytochemical Analysis
To monitor the morphologic conversion of the squamous to the mucous phenotype, histologic and cytologic preparations were obtained from RA-deficient cultures and from cultures treated for 4 d with 10 Ϫ6 M RA. Figures 3A  and 3B show the progression in RA-deficient cultures from a thin layer of squamous epithelium on Day 7 to a multilayered squamous epithelium on Day 11. Cultures treated from Day 7 to Day 11 with RA ( Figure 3C ) exhibited a cuboidal to low columnar epithelium with only a thin sheet of flattened cells remaining at the apical surface. RA-deficient cultures on Day 10 ( Figure 3D ) revealed a stratified squamous epithelium that became extensively cornified by Day 14 ( Figure 3E ). After 4 d of RA treatment beginning on Day 10 ( Figure 3F ), the squamous epithelium was converted to a polarized columnar epithelium. Only a thin layer of flattened cells remained on the apical surface and desquamation of entire sheets of cells was evident.
Cells obtained from enzymatically dissociated cultures were stained with antimucin antibody. Between 1% and 3% of the cells from Day 10 and Day 14 RA-deficient cultures ( Figures 3G and 3H ) showed a weak, diffuse cytoplasmic staining with antimucin antibody. In contrast, many cells ‫ف(‬ 40%) obtained from cultures treated from Day 10 to Day 14 with 10 Ϫ6 M RA reacted strongly with antimucin antibody ( Figure 3I) , with many cells containing positively stained cytoplasmic granules. Thus the biochemical changes described in Figures 1 and 2 accompanied the morphologic remodeling in the cultures that led to the reestablishment of a mucous epithelium.
Kinetics of Induction of the Mucous Phenotype by RA
We wanted to establish the temporal relationship between the induction of mucin genes, mucin secretion, the appearance of mucous cells, and suppression of the squamous cell marker cornifin ␣, following treatment of RA-deficient cultures with a maximally effective concentration of RA. Therefore, RA-deficient cultures were treated on Day 10 with 10 Ϫ6 M RA, and at different time intervals the levels of cornifin ␣ and mucin mRNAs, as well as the number of mucous cells and the amount of secreted mucin, were determined.
As shown in Figure 4A , cornifin ␣ mRNA levels were decreased within 12 h of RA treatment and remained suppressed thereafter. MUC2 mRNA was upregulated within 24 h and the level of expression continued to increase thereafter. MUC5AC mRNA was not detectable until 48 h after the start of treatment, and its level of expression continued to increase at subsequent time points. We also included MUC5B mRNA measurements in this study because this mucin was recently shown to be an important component of human airway secretions (21) . Interestingly, MUC5B mRNA was not increased until 72 h after RA treatment. Low levels of MUC5B mRNA were sometimes seen in RA-free cultures. The control gene ␤2M was not significantly affected by RA treatment. Our data show a distinct time course of events induced by RA treatment: The squamous marker cornifin ␣ was suppressed first, followed by sequential expression of the three mucin genes. This time-dependent change in cornifin ␣ and mucin gene expression was observed in two independent experiments.
As shown in Figure 4B , mucin secretion did not increase significantly above control levels until 72 h after addition of RA to the cultures. However, the number of cells staining with the mucin antibody ( Figure 4C ) was markedly increased above that in control cultures within 24 h, and more than 15% of the cells reacted with the antibody. Thereafter the number of mucous cells continued to increase to nearly 40%. These results suggest that mucin accumulated in cells before significant amounts of mucin were secreted onto the apical surface.
Enhancement of Mucin Gene Expression in RA-Supplemented Cultures by High Concentrations of RA
The foregoing experiments on the time-dependent effects of RA treatment of RA-deficient cultures showed that between 24 and 72 h elapsed before the mRNA levels of the three mucin genes were measurably increased. We wondered whether mucin gene expression could be more rapidly upregulated in RA-sufficient cultures maintained in 10 Ϫ8 M by raising the levels of RA to 10 Ϫ6 M. NHTBE cells were grown in medium containing a basal level of 10 Ϫ8 M RA. On Day 10 the RA concentration was increased to 10 Ϫ6 M, and MUC2, MUC5AC, and MUC5B mRNA levels were determined 6, 12, 24, 48, and 96 h later. The results of the experiment are shown in Figure 5 . Increasing the RA concentration from 10 Ϫ8 M to 10 Ϫ6 M increased MUC2 mRNA levels within 6 h (6-fold above untreated control cultures). Expression of MUC5AC and MUC5B mRNA was not significantly increased by raising the RA level 100-fold; mucin secretion was not increased (data not shown). The control gene ␤2M was not affected. The same results were obtained in a repeat experiment. These data indicate that in cultures in which the cells are already committed to express the mucous phenotype, MUC2 mRNA levels are much more rapidly increased than in RA-deficient cultures treated with the same concentration of RA.
Discussion
The importance of retinoids as regulators of cell differentiation has been recognized for many years (for review, see Reference 34) . Depending on the cell or tissue type, retinoids can either induce or inhibit the differentiation process. For instance, in the F9 embryonal teratocarcinoma cells, RA induces differentiation to parietal endoderm (35) . In contrast, in epidermal keratinocytes, RA inhibits differentiation (36) .
Previously we showed that two mucin genes that are expressed in RA-sufficient NHTBE cultures, namely, MUC2 and MUC5AC, are not expressed when RA is omitted from the medium (12) . Such cultures are uniformly squamous metaplastic and secrete no mucin (15) . In our study, we describe the molecular and cellular changes during epithelial remodeling leading to the restoration of the mucous phenotype following RA treatment of RA-depleted squamous cultures.
We used two markers to monitor changes in NHTBE cell differentiation. Cornifin ␣ was employed as a marker of squamous differentiation and secreted mucin to moni- tor mucous cell differentiation. The antibodies used in this study were previously shown to react with human mucin but are not known to be directed against specific mucin subtypes. Such mucin subtype-specific antibodies have only recently been produced (19) but are not yet readily available. To what extent changes in expression of specific mucin genes will result in altered production of the corresponding gene products remains to be determined in the future.
Our studies showed that RA-deficient cultures in advanced stages of squamous differentiation were much less responsive to RA treatment than were cultures in early stages of squamous differentiation. In late squamous cultures, 10 times as much RA was required to induce similar levels of MUC2 and MUC5AC gene expression and to suppress cornifin ␣ than in early squamous cultures. However, the late squamous cultures were by no means completely RA resistant. Treatment with 10 Ϫ6 M RA resulted in morphologic conversion to the mucous phenotype and in induction of mucin mRNAs. The reasons for this difference in RA responsiveness between early and late fully differentiated squamous cultures are presently not clear. A comparison of the histomorphology of the early and late RA-deficient cultures (compare Figure 3A with Figure  3D ) suggests that the thick, stratified epithelium of the Day 10 cultures contains many more cells committed to squamous differentiation than the Day 7 cultures, in which only a thin sheet of squamous cells overlays a row of seemingly undifferentiated basal cells. A much more extensive process of epithelial remodeling, and thus a more intensive RA treatment, is required to convert the late squamous cultures to the mucous phenotype than to redirect differentiation in the early squamous cultures. It is also conceivable that retinoid receptors or other transcription factors essential for mucin gene transcription are declining with protracted retinoid deficiency, or that RA metabolism and transport are altered in such a way in the late squamous cultures that RA treatment is less efficient.
The kinetics of restoration of the mucous phenotype triggered by RA treatment of RA-deficient cultures are depicted in Figure 6 . As shown, the squamous differentiation marker cornifin ␣ was suppressed before any of the three mucin genes studied were induced. This may be an indication that the first step in the conversion of the squamous to the mucous phenotype is downregulation of the squamous differentiation program. The earliest sign that mucous differentiation was being induced was the expression of the mucin gene MUC2 at 24 h and, simultaneously, the appearance of a significant number of mucous cells. Our studies support earlier in vivo experiments in vitamin A-deprived hamsters, which showed that within 24 h after the start of vitamin A treatment small PAS-positive vacuoles, presumed to be mucous granules, appeared in the squamous lesions of the airways (5). Thus, in vivo as well as in vitro remodeling of the vitamin A deficient metaplastic epithelium appears to commence soon after the start of vitamin A treatment. MUC5AC mRNA was first expressed at 48 h and MUC5B at 72 h after addition of RA to the cultures. Expression of the latter coincided with the onset of apical secretion of mucin. We propose that this sequence of events following RA treatment of the NHTBE cultures indicates progressive stages of mucous cell differentiation and maturation.
Upregulation of the mucin genes in RA-deficient cultures by RA treatment is not a typical "early" response comparable to RAR␤ receptor or Hox a1 induction, which occurs within 2 or 8 h following RA treatment of hepatoma-derived cells or F9 teratocarcinoma cells (37, 38) . Rather, the induction of these mucin genes resembles the delayed response of laminin b1, a high molecular weight glycoprotein secreted by F9 cells treated with RA (39) . Upregulation of laminin b1 transcription by RA may involve not only binding of RARs to retinoic acid response elements (RARE), but also activation of a homeodomain gene (39) , thus perhaps explaining the delayed response. Because the MUC2 promoter as published by Velcich and colleagues (40) and Gum and coworkers (41) does not contain canonical RAREs, it is likely that the transcriptional activation of MUC2 expression also involves complex regulatory mechanisms. Promoter sequences of MUC5AC and MUC5B have not been published at the time of submission of this report. The RA time course studies suggest that the induction of MUC2, MUC5AC, and MUC5B expression may involve different mechanisms because the different mucin genes are induced at different times after RA addition to the cultures. Previous studies in which we showed that thyroid hormone preferentially inhibits MUC5AC expression (14) also suggest that MUC2 and MUC5AC are differentially regulated.
In the RA-deficient cultures, the epithelium underwent a massive change in its normal differentiation program, resulting in expression of the squamous phenotype with little or no mucin gene expression. Under these conditions, at least 24 h of RA treatment were required to induce any mucin genes. We wanted to determine whether mucin gene expression can be more rapidly upregulated when cultures, in which the normal mucous phenotype is maintained by relatively low levels of RA (10 Ϫ8 M), are acutely treated with high concentrations of RA. We found that within 6 h of treatment with 10 Ϫ6 M RA, MUC2 transcript levels were elevated. Because the epithelium in these cultures was already committed to mucous differentiation, cytoplasmic and nuclear factors needed for upregulation of MUC2 mRNA must have been present before the RA level was increased. Under these experimental conditions MUC5AC and MUC5B mRNA levels were increased only marginally by the high-dose RA treatment, possibly because expression levels were already near maximum in the control cultures maintained in 10 Ϫ8 M RA. Other factors, including tumor necrosis factor ␣ and lipopolysaccharides (LPS) have been shown to upregulate MUC2 mRNA rapidly in human lung carcinoma cells (18, 22) . Our studies showed that RA treatment can also rapidly upregulate MUC2 mRNA in NHTBE cultures expressing the mucous phenotype. In contrast, in vitamin A-deprived cultures, the effect of RA treatment on mucin gene expression is a delayed response. This raises the possibility that RA acts via two different mechanisms: one that regulates MUC2 expression more directly through regulation of transcription or mRNA stability and one that involves changing a differentiation program, as a result of which mucin genes become expressed. Such a dual mechanism of action of RA was also proposed for the effects of retinoids on keratinocyte differentiation and keratin gene expression (42) .
Recent studies suggest that MUC5AC and MUC5B mucins are major components of human airway secretions (17, 19) . MUC2, on the other hand, does not appear to be a prominent airway mucin (17, 19) . However, it has been shown that MUC2 mRNA is expressed in goblet cells of human bronchial (43) and nasal epithelium (44) and that expression levels are upregulated in cultured airway epithelial cells by cytokines (22) and LPS (18) . It is intriguing that MUC2 is the first of the three mucin genes expressed during restoration of the mucous phenotype and thus may serve as an early marker of mucous differentiation. What role it might play in the differentiation process of mucous cells is presently unknown. It will be interesting to determine, when mucin subtype-specific antibodies become available, whether intracellular MUC2 mucin can be detected in the early mucous cells appearing within the first 24 h after RA treatment. On the basis of immunohistochemistry or in situ hybridization studies, at least two other mucins, MUC4 and MUC8, may also be components of human airway secretions (45) (46) (47) . We plan to include these mucin genes in future studies of mucous differentiation and mucin gene expression.
Our studies showed that in the restoration of the mucous phenotype by RA treatment of RA-deficient NHTBE cultures, induction of the mucin gene MUC2 and intracellular accumulation of mucin occurred first, and MUC5AC and MUC5B were expressed at later stages of mucous differentiation. To further elucidate mechanisms by which retinoids regulate mucous differentiation and mucin gene expression, studies are underway to determine which retinoid receptors are critical in the RA signaling pathway.
